Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/7/23 16:03 | 11/6/23 | THRX | Health | Drug | Pharmaceutical Preparations | Shakespeare William | MA | O | See Rema | M.d | 80 | 0.3200 | 0 | 251 | 65 | 639 | D | ||||||||||||||
7/19/23 16:17 | 7/17/23 | THRX | Health | Drug | Pharmaceutical Preparations | Gordon Carl L | MA | DT | P | 1,464 | 3.05 | 0 | 480 | 281 | 651 | I | |||||||||||||||
7/19/23 16:15 | 7/17/23 | THRX | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | DT | P | 1,464 | 3.05 | 0 | 480 | 281 | 651 | I | |||||||||||||||
7/19/23 14:54 | 7/17/23 | THRX | Health | Drug | Pharmaceutical Preparations | Foresite Capital Management V, LLC | CA | T | P | 2,079 | 2.97 | 0 | 700 | 102 | 1,386 | I | |||||||||||||||
1/3/23 16:24 | 12/29/22 | THRX | Health | Drug | Pharmaceutical Preparations | Foresite Capital Management V, LLC | CA | T | P | 2,500 | 5.00 | 0 | 500 | 70 | 1,209 | I | |||||||||||||||
1/3/23 07:05 | 12/29/22 | THRX | Health | Drug | Pharmaceutical Preparations | Hayden Donald J Jr | MA | D | P.m | 50 | 5.00 | 0 | 10 | New | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |